|
|
|
| Association between types of obesity and atherosclerotic cardiovascular disease risk among hypertensive patients |
| GUO Yanqiang1, ZHANG Li1, ZHANG Lan2, HAN Rongrong1
|
1. Linping District Center for Disease Control and Prevention (Linping District Institute of Public Health Supervision), Hangzhou, Zhejiang 311100, China;
2. Donghu Street Community Health Service Center, Linping District, Hangzhou, Zhejiang 311100, China |
|
|
|
|
Abstract Objective To explore the association between types of obesity and 10-year risk of atherosclerotic cardiovascular disease (ASCVD) among hypertensive patients, so as to provide the basis for formulating ASCVD prevention strategies for hypertensive patients. Methods From January to December 2021, hypertensive patients who were under follow-up management and completed health examinations at three community health service centers in Linping District, Hangzhou City were selected by a cluster sampling method. Basic information, lifestyle, disease history, height, weight, waist circumference (WC), and blood biochemical indicators were collected through health examination data. Based on assessments of body mass index (BMI) and WC, participants were categorized into four types: non-obese, general obesity only, central obesity only, and combined obesity. The Prediction for ASCVD risk in China (China-PAR) was used to assess 10-year ASCVD risk, which was categorized as low, moderate, and high risk. Multivariable logistic regression models were used to analyze the association between different types of obesity and ASCVD risk among hypertensive patients. Results A total of 10 408 hypertensive patients were included, with a median age of 68.00 (interquartile range, 10.00) years. There were 4 301 (41.32%) males and 6 107 (58.68%) females. The proportions of non-obese, general obesity only, central obesity only, and combined obesity were 34.93% (3 635 individuals), 22.85% (2 378 individuals), 4.32% (450 individuals), and 37.90% (3 945 individuals), respectively. There were 3 389 (33.52%) cases at high risk of ASCVD. Among them, high ASCVD risk was observed in 1 107 (30.45%), 896 (37.68%), 122 (27.11%), and 1 364 (34.58%) patients with non-obese, general obesity only, central obesity only, and combined obesity, respectively. Multivariable logistic regression analysis showed that after adjusting for gender, age, smoking, drinking, physical activity, and diabetes, the risk of high ASCVD in hypertensive patients with general obesity only and combined obesity was 1.383 times (95%CI: 1.235-1.548) and 1.225 times (95%CI: 1.109-1.354) that of non-obese hypertensive patients, respectively. Conclusions General obesity only and combined obesity can increase the 10-year high risk of ASCVD among hypertensive patients. It is necessary to strengthen comprehensive management of body weight and WC among hypertensive patients to reduce the risk of ASCVD.
|
|
Received: 03 October 2025
Revised: 07 January 2026
Published: 26 January 2026
|
|
|
|
|
|
[1] 国家心血管病中心,中国心血管健康与疾病报告编写组,胡盛寿.中国心血管健康与疾病报告2024概要[J].中国循环杂志,2025,40(6):521-559.
[2] 淡亮星,谢华兵,刘志辉,等.全科医学视角下的动脉粥样硬化性心血管疾病一级预防[J].中华全科医师杂志,2025,24(6):656-662.
[3] KOSKINAS K C,VAN CRAENENBROECK E M,ANTONIADES C,et al.Obesity and cardiovascular disease:an ESC clinical consensus statement[J].Eur J Prev Cardiol,2025,32(3):184-220.
[4] 黄飞,朱进华,华召来,等.40~69岁居民肥胖类型与心血管危险因素的关联分析[J].现代预防医学,2023,50(13):2305-2310,2343.
[5] YANG X L,LI J X,HU D S,et al.Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population:the China-PAR project(prediction for ASCVD risk in China)[J].Circulation,2016,134(19):1430-1440.
[6] 李清霖,张宇清.国内外高血压指南心血管疾病风险评估系统综述[J/OL].中国医学前沿杂志(电子版),2020,12(7):33-40.
[7] 庞林鸿,赵雅静,朵林,等.云南省成年居民代谢综合征患病现状及其影响因素分析[J].中国公共卫生,2023,39(5):617-621.
[8] BULL F C,AL-ANSARI S S,BIDDLE S,et al.World Health Organization 2020 guidelines on physical activity and sedentary behaviour[J].Br J Sports Med,2020,54(24):1451-1462.
[9] 中国高血压修订委员会,高血压联盟,中华医学会心血管病学分会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.
[10] 中华医学会糖尿病学分会.中国糖尿病防治指南(2024版)[J].中华糖尿病杂志,2025,17(1):16-139.
[11] 王增武,刘静,李建军,等.中国血脂管理指南(2023年)[J].中国循环杂志,2023,38(3):237-271.
[12] 中华人民共和国国家卫生和计划生育委员会.成人体重判定:WS/T 428—2013[S].北京:中国质检出版社,中国标准出版社,2013.
[13] 张海峰,靳迪,吕宪玉,等.北京某三甲医院体检人群不同肥胖类型与骨密度及握力的相关性分析[J].解放军医学院学报,2020,41(7):666-669,674.
[14] 中国心血管病风险评估和管理指南编写联合委员会.中国心血管病风险评估和管理指南[J].中华预防医学杂志,2019,53(1):13-35.
[15] JIA X J,HU C Y,XU Y,et al.Revisiting obesity thresholds for cardiovascular disease and mortality risk in Chinese adults:age-and gender-specific insights[J/OL].Cell Rep Med,2025,6(9)[2026-01-07].https://doi.org/10.1016/j.xcrm.2025.102309.
[16] 张迷磊,杨琼,陈海燕,等.肥胖类型与壮族中老年居民心血管疾病危险因素发生及聚集情况的分析[J].广西医科大学学报,2023,40(9):1564-1569.
[17] POWELL-WILEY T M,POIRIER P,BURKE L E,et al.Obesity and cardiovascular disease:a scientific statement from the American heart association[J].Circulation,2021,143(21):984-1010.
[18] 孔洁,黄攀登,任东静,等.中老年人群内脏脂肪代谢水平与心血管疾病的关联研究[J].预防医学,2025,37(12):1228-1232.
[19] TEMU T M,MACHARIA P,MTUI J,et al.Obesity and risk for hypertension and diabetes among Kenyan adults:Results from a national survey[J/OL].Medicine,2021,100(40)[2026-01-07].https://doi.org/10.1097/MD.0000000000027484.
[20] ROSS R,NEELAND I J,YAMASHITA S,et al.Waist circumference as a vital sign in clinical practice:a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity[J].Nat Rev Endocrinol,2020,16(3):177-189.
[21] MUSCOGIURI G,VERDE L,VETRANI C,et al.Obesity:a gender-view[J].J Endocrinol Investig,2024,47(2):299-306.
[22] ZHOU T,YUAN C X,SHEN C,et al.Association between physical activity and incident atherosclerotic cardiovascular disease is modified by predicted cardiovascular risk:The China-PAR project[J/OL].J Sport Health Sci,2025,14[2026-01-07].https://doi.org/10.1016/j.jshs.2025.101031.
[23] GOWER B,BLACKET C,GIRARD D,et al.Prospective associations between systolic blood pressure,serum cholesterol,and physical activity behaviour and the development of cardiovascular disease[J/OL].Prev Med,2024,183[2026-01-07].https://doi.org/10.1016/j.ypmed.2024.107958.
[24] GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440):2100-2132. |
|
|
|
